COST
Action B22 on "Drug development for parasitic diseases"
2003-2007
Economic dimension
The following COST
countries have actively participated in the preparation of the
Action or otherwise indicated their interest:
UK, Belgium, France, Germany, Netherlands, Denmark, Spain, Switzerland, Austria, Czech Republic, Portugal and Israel.
On the basis of national estimates provided by the representatives of these countries, the economic dimension of the activities to be carried out under the Action has been estimated, in 2002 prices, at roughly Euro 30 Million.
This estimate is valid under the assumption that all the countries mentioned above but no other countries will participate in the Action. Any departure from this will change the total cost accordingly.